Mammalian target of rapamycin complex 2 (mTORC2) controls glycolytic gene expression by regulating Histone H3 Lysine

Raghavendra Vadla1,2, Devyani Haldar1

  • 1a Centre for DNA Fingerprinting and Diagnostics , Survey Nos. 728, 729, 730 & 734, Opposite Uppal Water Tank, Beside BSNL T E Building, Uppal, Hyderabad 500039 , Ranga Reddy District , India.

Insights

Mammalian target of rapamycin complex 2 (mTORC2) promotes histone H3 lysine 56 acetylation (H3K56Ac) in glioma. This epigenetic modification regulates glycolytic gene expression, suggesting a novel mechanism for cancer metabolic reprogramming.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Metabolic reprogramming is crucial for cancer development.
  • The mammalian target of rapamycin complex 2 (mTORC2) influences cell growth and metabolism.
  • The role of mTORC2 in epigenetic regulation of gene expression in glioma remains unclear.

Purpose of the Study:

  • To investigate the role of mTORC2 in epigenetic modifications in glioma.
  • To determine if mTORC2 regulates histone H3 lysine 56 acetylation (H3K56Ac).
  • To elucidate the mechanism by which mTORC2 influences gene expression and metabolic reprogramming in glioma.

Main Methods:

  • Knockdown of mTORC2 and mTORC1 to assess effects on H3K56Ac levels.
  • Investigated the involvement of tuberous sclerosis complex 1/2 (TSC1/2) and sirtuin6 (SIRT6) in the mTORC2-mediated H3K56Ac pathway.
  • Utilized a glioma cell model (U87EGFRvIII) to study mTORC2's role in H3K56Ac.
  • Analyzed H3K56Ac levels at the promoters of glycolytic genes.

Main Results:

  • mTORC2 knockdown, but not mTORC1 knockdown, led to decreased global H3K56Ac levels.
  • mTORC2 promotes H3K56Ac via a TSC1/2-mediated pathway.
  • SIRT6 knockdown prevented H3K56 deacetylation in mTORC2-depleted cells.
  • mTORC2 was confirmed to promote H3K56Ac in glioma cells.
  • mTORC2 regulates glycolytic gene expression by modulating H3K56Ac at gene promoters.
  • mTORC2 depletion increased SIRT6 recruitment to these promoters.

Conclusions:

  • mTORC2 signaling positively regulates H3K56Ac in glioma.
  • mTORC2-mediated H3K56Ac is a key mechanism in glioma metabolic reprogramming.
  • This study identifies a novel link between mTORC2, epigenetic modification, and cancer metabolism.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.7K
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
16.4K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.9K